Retrospective Study of Surgical Outcomes in 60 Patients with Crohn Disease from a Single Center in Poland

12 January 2022: Clinical Research

Karolina Majewska ^1BCDEF* , Cezary Rusinowski ^1BCD , Beata Jabłońska ^2ACDE , Dariusz Gołka ^3E , Sławomir Mrowiec ^2AE

DOI: 10.12659/MSM.934463

Med Sci Monit 2022; 28:e934463

Table 1 The general patient clinical characteristics.

Mean age	38 (±10.4)
Mean age at diagnosis (years)	31 (±10)
Disease duration (years)	6.3 (±5.9)
Montreal classification:
n=57
A1 (≤16)	n=1 (1.7%)
A2 (17–40)	n=46 (76.7%)
A3 (>40)	n=10 (16.7%)
n=58
L1 (ileal)	n=3 (5%)
L2 (colonic)	n=9 (15%)
L3 (ileocolonic)	n=46 (76.7%)
L4 (upper GI – jejunum, duodenum, gaster)	n=4 (7%)
	L1+L4 (n=1)
	L3+L4 (n=3)
n=59
B16	n=7 (11.7%)
B2	n=15 (25%)
B3	n=15 (25%)
B2+B3	n=22 (36.7%)
Perianal disease (p)	n=11 (18.3%)
Presence of fistulae and abscesses^*
Fistulae	n=37 (61.7%)
Abscesses	n=25 (41.7%)
Use of biological therapy n=59	n=19 (31.7%)
Use of glucocorticoids	n=23 (38.3%)
Use of azathioprine	n=26 (43.3%)
Use of mercaptopurine	n=11 (18.3%)
Current smoker n=60	n=13 (21.7%)
BMI n=60	20.9 (±3.95)
Underweight (	n=19 (31.7%)
Normal weight (18.5–24.9)	n=32 (53.3%)
Overweight (25–29.9)	n=8 (13.3%)
Obese (≥30)	n=1 (1.7%)
^* Current or in medical history. BMI – body mass index.